Medlab Clinical (MDC)
Medlab Clinical Ltd. is a pharmaceutical company. The company engages in the research, development, production and sale of nutraceutical and pharmaceutical drugs. Its business involves in the research of probiotics with focus in the area of obesity, chronic kidney disease, depression, anti ageing and pain management. The company's products include Enbiottic, MultiBiotic 30's, MultiBiotic 60's, NanoCelle B12, NanoCelle D3, and NRGBiotic. Medlab Clinical was founded by Sean Hall in August 2012 and is headquartered in Alexandria, Australia.
|Market Price at 17-11-2017||$0.69|
|Price to Earnings Ratio||-42.9|
|Market Capitalisation||$122.41 (million)|
|Return on Equity (ROE)||-89.95%|